1,3-Dimethylamylamine Research Overview
1,3-Dimethylamylamine (DMAA) is a synthetic aliphatic amine compound extensively investigated in laboratory settings for its neurochemical properties and stimulatory mechanisms. Originally developed by Eli Lilly in the 1940s, DMAA demonstrates significant research value in understanding sympathomimetic amine interactions and their effects on neurotransmitter systems. Research laboratories at Stroid UK Shop frequently examine this compound for its unique molecular profile and potential applications in pre-workout formulation studies.
The compound’s molecular structure enables selective research into adrenergic receptor binding patterns and dopaminergic pathway modulation in controlled laboratory environments. Scientific investigations have focused on DMAA’s ability to cross blood-brain barriers in research models, making it valuable for neurochemical studies. Researchers studying DMAA compounds often examine its interactions with monoamine transporters and its effects on neurotransmitter reuptake mechanisms in cellular assays.
Laboratory Research Applications
In vitro studies examine DMAA’s pharmacokinetic properties, including its absorption, distribution, and metabolic pathways in tissue culture models. Research applications extend to investigating the compound’s thermogenic properties and its interactions with beta-adrenergic receptors in laboratory settings. Scientists frequently compare DMAA’s molecular behaviour with other stimulant compounds used in SARM research protocols to understand structural activity relationships. Laboratory investigations also focus on DMAA’s potential synergistic effects when combined with other research chemicals, particularly in formulations designed for metabolic studies. Advanced research protocols examine the compound’s stability under various storage conditions and its compatibility with other laboratory compounds used in peptide research environments.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 1,3-Dimethylamylamine |
| CAS Number | 13803-74-2 |
| Molecular Formula | C₇H₁₇N |
| Molecular Weight | 115.22 g/mol |
| Purity | Verify with supplier |
| Storage Temperature | Room temperature, dry environment |
| Physical Form | Powder formulation |
| Solubility | Water soluble |
Research Compliance and Safety
This DMAA research compound is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must follow appropriate laboratory safety protocols when handling this compound and ensure compliance with institutional research guidelines. All studies involving this compound should be conducted under proper laboratory supervision with adequate ventilation and safety equipment.
